Dianthus Therapeutics

DNTH

Market cap $5.21B

Upgrade to unlock

Buy

Hold

Sell

9 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$128

38% upside

High target

9 analyst ratings

positive

0 neutral

0%

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Wedbush Laura Chico 75% 1-yr DNTH win rate				12 Mar ‘26 1 month ago
Raymond James Steve Seedhouse 50% 1-yr DNTH win rate				10 Mar ‘26 1 month ago
Baird Joel Beatty 67% 1-yr DNTH win rate				10 Mar ‘26 1 month ago
Clear Street Bill Maughan 50% 1-yr DNTH win rate				10 Mar ‘26 1 month ago
HC Wainwright & Co Swayampakula Ramakanth 100% 1-yr DNTH win rate				9 Mar ‘26 1 month ago
Oppenheimer Leland Gershell 100% 1-yr DNTH win rate				9 Mar ‘26 1 month ago
Truist Securities Danielle Brill 100% 1-yr DNTH win rate				9 Mar ‘26 1 month ago
Guggenheim Yatin Suneja 100% 1-yr DNTH win rate				4 Mar ‘26 1 month ago
Jefferies Maury Raycroft 100% 1-yr DNTH win rate				2 Feb ‘26 2 months ago